AtheroGenics, Inc. (AGIX)

CAPS Rating:

The Company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, including coronary heart disease, organ transplant rejection, rheumatoid arthritis and asthma.

View All Commentary (AGIX)